BioCentury
ARTICLE | Company News

Aqua Pharmaceuticals, GlaxoSmithKline sales and marketing update

June 17, 2013 7:00 AM UTC

Aqua acquired U.S. rights to Verdeso 0.05% desonide foam from GlaxoSmithKline's Stiefel Laboratories Inc. subsidiary. The low-potency topical steroid formulated with 0.05% desonide in emollient foam...